Dr. Don Morris, MD PhD
Claim this profileTom Baker Cancer Centre
Studies Breast Cancer
Studies Glioblastoma
3 reported clinical trials
4 drugs studied
Area of expertise
1Breast Cancer
Stage IV
HER2 negative
PR negative
2Glioblastoma
IDH negative
Affiliated Hospitals
Clinical Trials Don Morris, MD PhD is currently running
Niacin CRT
for Glioblastoma
This study is evaluating whether a new drug called Niacin CRT™ can improve the survival of people with glioblastoma.
Recruiting1 award Phase 1 & 211 criteria
Palliative Care
for Blood Cancer
Research has shown that early palliative care in cancer care is associated with improved symptom management, better prognostic understanding, improved quality of life for patients and family caregivers, and even improved survival. Yet, in spite of the proven benefits of integration of palliative care in oncology, it has been well established that patients with hematologic malignancies and those undergoing cellular therapy (hematopoietic stem cell transplantation (HSCT) and chimeric antigen receptor (CAR) T-cell therapy) do not routinely receive palliative care. Most of the published research on the early integration of palliative care in oncology describes studies that have involved patients with solid tumours. To date, only one randomized trial examining the impact of integrated palliative care among patients undergoing HSCT has been published and there have been no studies examining the impact of integrated palliative care for patients undergoing CAR T-cell therapy. The American Society of Clinical Oncology recommends early palliative care for patients with advanced cancers or for those with high symptom burden. Patients with blood cancers experience high symptom burden and in the last 30 days of life, compared to patients with solid tumours, patients with blood cancers are more likely to die in hospital, have more intensive care unit admissions, have prolonged hospitalizations (\>14 days), and pass away in an acute care facility. There is an urgent need to proactively address suffering throughout cellular therapy trajectories, even before treatment starts, so that patients and caregivers are not inevitably waiting for symptoms to arise before they can be addressed and to optimize quality of life for patients undergoing transplant as well as their family caregivers. PALS_CT will compare early palliative care to standard care for patients and their family caregivers undergoing HSCT or CAR T-cell therapy for blood cancers.
Recruiting1 award N/A5 criteria
More about Don Morris, MD PhD
Clinical Trial Related3 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Don Morris, MD PhD has experience with
- Temozolomide
- Olaparib
- Niacin CRT
- Early Palliative And Supportive Care
Breakdown of trials Don Morris, MD PhD has run
Breast Cancer
Glioblastoma
Leukemia
Blood Cancers
CAR-T Therapy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Don Morris, MD PhD specialize in?
Don Morris, MD PhD focuses on Breast Cancer and Glioblastoma. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Don Morris, MD PhD currently recruiting for clinical trials?
Yes, Don Morris, MD PhD is currently recruiting for 2 clinical trials in Calgary Alberta. If you're interested in participating, you should apply.
Are there any treatments that Don Morris, MD PhD has studied deeply?
Yes, Don Morris, MD PhD has studied treatments such as Temozolomide, Olaparib, Niacin CRT.
What is the best way to schedule an appointment with Don Morris, MD PhD?
Apply for one of the trials that Don Morris, MD PhD is conducting.
What is the office address of Don Morris, MD PhD?
The office of Don Morris, MD PhD is located at: Tom Baker Cancer Centre, Calgary, Alberta T2N 4N2 Canada. This is the address for their practice at the Tom Baker Cancer Centre.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.